BURN-X cpr pell 20 mg 14 pce

7680688140125 Pharmacode 1034353 CH-68814 A02BC05 04.99.0.
BURN-X cpr pell 20 mg 14 pce
BURN-X cpr pell 20 mg 14 pce
BURN-X cpr pell 20 mg 14 pce
1 / 3
google

Details

GTIN
7680688140125
Pharmacode
1034353
Product number
6881401
CPT
-
Packaging group
14
Unit
Tablette(n)
Composition
esomeprazolum 20 mg ut esomeprazolum magnesicum dihydricum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas, polysorbatum 80, talcum, triethylis citras, hypromellosum, sacchari sphaerae, magnesii stearas, hydroxypropylcellulosum, glyceroli monostearas 40-55, polysorbatum 80, cellulosum microcristallinum, povidonum, macrogolum 6000, crospovidonum, natrii stearylis fumaras, Überzug: hypromellosum, E 171, macrogolum 400, E 172 (rubrum), E 172 (flavum) pro compresso obducto corresp. natrium 0.082 mg.

Articles (1)

Burn-X, magensaftresistente Tabletten
Magensaftresistente Tabletten
14
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
esomeprazolum
20.0 MG Substance Wirkstoff (Principe actif)
esomeprazolum magnesicum dihydricum
- Substance WIZUS
acidi methacrylici et ethylis acrylatis polymerisatum 1:1
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
polysorbatum 80
- Substance HNIDK
talcum
- Substance HNIDK
triethylis citras
- Substance HNIDK
hypromellosum
- Substance HNIDK
sacchari sphaerae
- Substance HNIDK
magnesii stearas
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
glyceroli monostearas 40-55
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
povidonum
- Substance HNIDK
macrogolum 6000
- Substance HNIDK
crospovidonum
- Substance HNIDK
natrii stearylis fumaras
- Substance HNIDK
hypromellosum
- Substance HNIDK
E 171
- Substance FNIDK
macrogolum 400
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
natrium
0.082 MG Substance HBESI

Authorization holder

axapharm ag

6340 Baar

Authorization information

Swissmedic authorization number
68814
Drug name
Burn-X, magensaftresistente Tabletten
Galenic form
MATB
ATC Code
A02BC05
Authorization status
Z
Dispensation category
D
First authorization
17/02/2022
Authorization expiration date
01/09/2026
IT number
04.99.0.
Domain
Human medicine
Field of application
Protonenpumpenblocker

Packaging details

Description (FR)
BURN-X cpr pell 20 mg 14 pce
Description (DE)
BURN-X Filmtabl 20 mg 14 Stk
Market launch
17/02/2022
Market withdrawal
30/08/2026
Narcotic (BTM)
No

Available generics

Esomep, MUPS-Tabletten
CHF 16.25
View
Esomep, MUPS-Tabletten
CHF 30.25
View
Esomep, MUPS-Tabletten
CHF 40.75
View
Esomep, MUPS-Tabletten
CHF 51.90
View
Esomep, MUPS-Tabletten
CHF 17.10
View
Esomep, MUPS-Tabletten
CHF 31.55
View
Esomep, MUPS-Tabletten
CHF 45.95
View
Esomep, MUPS-Tabletten
CHF 59.65
View
Esomeprazol Axapharm, magensaftresistente Tabletten
CHF 15.35
View
Esomeprazol Axapharm, magensaftresistente Tabletten
CHF 28.40
View

Other packaging sizes

BURN-X cpr pell 20 mg 7 pce
7 TABL
View
Buy us a coffee Explore the data